Variant report
Variant | esv3375769 |
---|---|
Chromosome Location | chr6:38278369-38278647 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12524225 | chr6:38278417-38278418 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs543315513 | chr6:38278423-38278424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563213156 | chr6:38278451-38278452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188852804 | chr6:38278452-38278453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545712823 | chr6:38278470-38278471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545773411 | chr6:38278480-38278481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528625573 | chr6:38278481-38278482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201305715 | chr6:38278484-38278485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375432942 | chr6:38278510-38278511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148537172 | chr6:38278552-38278553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112925381 | chr6:38278569-38278570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200314411 | chr6:38278570-38278571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542674813 | chr6:38278575-38278576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544866899 | chr6:38278579-38278580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs201722881 | chr6:38278602-38278603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562401410 | chr6:38278608-38278609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562074977 | chr6:38278609-38278610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs180676550 | chr6:38278610-38278611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540156364 | chr6:38278618-38278619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553557085 | chr6:38278647-38278648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Lung cancer | 19153074 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 21693616 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Breast cancer | 16397240 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:38274400-38288600 | Weak transcription | Duodenum Mucosa | Duodenum |
2 | chr6:38275400-38301200 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
3 | chr6:38276000-38286200 | Weak transcription | Primary T cells from cord blood | blood |
4 | chr6:38276000-38287600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr6:38276000-38287800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
6 | chr6:38276200-38286800 | Weak transcription | HSMMtube | muscle |
7 | chr6:38277600-38278400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr6:38277800-38278800 | Enhancers | Psoas Muscle | Psoas |
9 | chr6:38277800-38279000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr6:38278000-38310600 | Weak transcription | Gastric | stomach |
11 | chr6:38278200-38283000 | Weak transcription | GM12878-XiMat | blood |
12 | chr6:38278200-38288000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr6:38278200-38295000 | Weak transcription | Lung | lung |
14 | chr6:38278400-38305400 | Weak transcription | Pancreas | Pancrea |